Modern Poultry Media
subscribe
Facebook-f Linkedin-in
translate
Search

MENU

Search
Facebook-f Linkedin-in
subscribe
translate
virus treated by autogenous aMPV type B vaccine
Merck Animal Health

6+ million birds protected against aMPV with first experimental autogenous vaccine produced in US

More than 6 million birds have been vaccinated against avian metapneumovirus (aMPV) type B since the September rollout of the first experimental autogenous vaccine produced in the US, according to Ivan Alvarado, PhD, associate director, scientific marketing affairs, Merck Animal Health.

focus on:

Industry insights:

Merck Animal Health

‘Cracking the code’ for better cocci control requires sharper focus on minor species

A sharper focus on minor coccidiosis species may be the key to improving management of this persistent parasitic disease and improving gut health, feed conversion and flock performance.

Copyright ©Feeks Media LLC, 2024 | All rights reserved
info@modernpoultry.media
privacy policy | site map